4//SEC Filing
Moore Matthew Richard 4
Accession 0001415889-24-013502
CIK 0001851194other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:20 PM ET
Size
5.9 KB
Accession
0001415889-24-013502
Insider Transaction Report
Form 4
Moore Matthew Richard
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-05-16+320,000→ 320,000 totalExercise: $4.98Exp: 2034-05-16→ Common Stock (320,000 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 16, 2024.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001840191
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:20 PM ET
- Size
- 5.9 KB